£795.00

The 2023-2028 World Outlook for Iron Deficiency Anemia Therapies

Subjects

Price data last checked 15 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days · 76 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 76 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (76 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 76 days

Description

This study covers the world outlook for iron deficiency anemia therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of iron deficiency anemia therapies as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Advanz Pharmaceutical, Akebia Therapeutics, Alkem Labs, Allergan, AMAG Pharmaceuticals, Avion Pharmaceuticals, CHO-A Pharmaceutical Company, Ltd., Fresenius Se & Company, GlaxoSmithKline, Hikma Pharmaceuticals, Johnson & Johnson, Keryx Biopharmaceuticals, Luitpold Pharmaceuticals, Lupin, Novartis, Orion, Pharmacosmos, Pieris Pharmaceuticals, Rockwell Medical, Sanofi, Shield Therapeutics, Teva Pharmaceutical Industries, ViforPharma, Ltd., and Zydus Cadila. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B09YHVC5NS
Category: Books > Subjects
Domain: Amazon UK
Release Date: 10 May 2022
Listed Since: 10 May 2022

The 2023-2028 World Outlook for Iron Deficiency Anemia Therapies

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in India

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in the United States

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in India

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in the United States

The 2023-2028 Outlook for Oral Iron Therapy for Iron Deficiency Anemia in India

The 2023-2028 Outlook for Oral Iron Therapy for Iron Deficiency Anemia in the United States

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in China

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in China

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies for US Zip Codes

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs for US Zip Codes

The 2016-2021 Outlook for Intravenous (IV) Iron Drugs in the United States

The 2016-2021 Outlook for Iron Compounds Excluding Iron Oxides, Hydroxides, and Ferric Chloride in Africa

The 2023-2028 Outlook for Iron Drugs for US Zip Codes

The 2023-2028 Outlook for Oral Iron Drugs for US Zip Codes

The World Market for Iron Less than 99.94% Pure or Steel Ingots and Other Primary Forms: A 2024 Global Trade Perspective

The World Market for Iron Less than 99.94% Pure or Non-Alloy Steel in Primary Forms Excluding Ingots: A 2022 Global Trade Perspective

The World Market for Iron Less than 99.94% Pure or Non-Alloy Steel in Primary Forms Excluding Ingots: A 2024 Global Trade Perspective

The World Market for Iron Less Than 99.94% Pure or Steel Ingots and Other Primary Forms: A 2021 Global Trade Perspective

Iron as Therapeutic Targets in Human Diseases: Volume 1

The World Market for Iron Less than 99.94% Pure or Non-Alloy Steel Ingots: A 2022 Global Trade Perspective

The World Market for Nonalloyed Pig Iron in Primary Forms with Less than 0.50% Phosphorus by Weight: A 2024 Global Trade Perspective

The 2013 Import and Export Market for Iron Less Than 99.94% Pure or Steel Ingots and Other Primary Forms in Latin America

The World Market for Iron Less Than 99.94% Pure or Non-alloy Steel In Primary Forms Excluding Ingots: A 2021 Global Trade Perspective

The World Market for Nonalloyed Pig Iron in Primary Forms with Less than 0.50% Phosphorus by Weight: A 2022 Global Trade Perspective